Address the deficiency leukocytes
The production of what is known stimuli development generators blood (hematopoietic growth factors), and also called the factors motivating for Reconstruction (Colony-stimulating factors CSFs), one of the most recent developments in the treatment of tumors, and is one of the natural ingredients produced by the body and has been prepared in the laboratory on widely, and act as stimulants of stem cells (stem cells) bone marrow, so urges and driven to increase the rates of reproduction and transformation for the production of blood cells of different, and are used in parallel with chemotherapy to help when frustration bone marrow and lower rates of blood cells, in order to reduce periods of shortages, and to be able to receive chemotherapy treatment without delay its long-term, and Bgerath specific treatment plans, in addition to being able to take high therapeutic doses required by some cases.
And there are two types of these catalysts are used when the white cell deficiency:
Incentives for Emaar granulosa cell (Granulocyte colony-stimulating factor G-CSF), and her name rolling commercially Valaqrastim (Filgrastim) or Nabujan (Neupogen), and are the cells stimulate the production of granulocytes.
Incentives for Emaar granulosa cell and macrophages (Granulocyte-macrophage colony-stimulating factor GM-CSF) and her name rolling Sariqramostim (sargramostim), and to eucaine (Leukine), and the induction is the production of each of the cells and granulosa cells Agma.
These catalysts are equipped with the form of injections, received intravenously or injected under the skin, and may be injected by the direct dose chemotherapy, or during or after the termination directly, and according to the planned therapeutic decision, and that was the usual injected after a day or so the end of the therapeutic doses.
It is worth mentioning that in addition to the use of both types to increase the rates of production of white blood cells, which reduces the risk of infection at times of need, are also used to raise the rate of production of stem cells in preparation for marrow transplant bone marrow.
(Please go to a page that immunotherapy for more details on development incentives).
